Activ Surgical is a digital surgery pioneer, envisioning a future of collaborative surgery, with surgical intelligence empowering scopes and robots to see what humans cannot see.
Activ Surgical has completed the world’s first autonomous robotic surgery of soft tissue, is building hardware-agnostic surgical software that allows surgical systems to collaborate with surgeons.
Activ Surgical was founded in 2017 by Peter Kim. The company is headquartered in Boston, Massachusetts.
Activ Surgical's patent-protected surgical software platform--ActiveEdge™--is being designed to reduce unintended and preventable surgical errors by enhancing a surgeon’s intraoperative decision-making via the aggregation of surgical data from around the world.
Activ Surgical recently launchedd ActivInsights™ augmented reality (AR)-based software suite, to enable autonomous and collaborative surgery through the integration of computer vision, artificial intelligence (AI), machine learning (ML), AR and robotics.
Activ Surgical is backed by Cota Capital, DNS Capital, GreatPoint Ventures (GPV), ARTIS Ventures, Tao Capital Partners, Hikma Ventures, LRVHealth, Rising Tide VC, SONY Innovation Fund, BAM Funds, 8VC, NVIDIA, and others. The company received an additional $15M in new financing on Mar 22, 2022. This is an extension of their previous $45M raised in Sep 2021, bringing the round total to $60M. The additional investment brings Activ Surgical's total funding to $92M to date.